Android app Apple app link

Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review

By Yahoo! Finance   |   4 weeks ago
Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review

Moderna, Inc. submits an updated COVID-19 vaccine, Spikevax, for FDA review targeting the LP.8.1 strain. The company aims to release the new vaccine by mid-August amid stricter FDA regulations for vaccine development.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.